Cargando…
Prevention of Chronic Experimental Colitis Induced by Dextran Sulphate Sodium (DSS) in Mice Treated with FR91
One of the main treatments currently used in humans to fight cancer is chemotherapy. A huge number of compounds with antitumor activity are present in nature, and many of their derivatives are produced by microorganisms. However, the search for new drugs still represents a main objective for cancer...
Autores principales: | Lombardi, Valter R. M., Etcheverría, Ignacio, Carrera, Iván, Cacabelos, Ramón, Chacón, Antonio R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3348609/ https://www.ncbi.nlm.nih.gov/pubmed/22619498 http://dx.doi.org/10.1155/2012/826178 |
Ejemplares similares
-
Effects of FR-91 on Immune Cells from Healthy Individuals and from Patients with Non-Hodgkin Lymphoma
por: Lombardi, V. R. M., et al.
Publicado: (2009) -
Calycosin attenuates dextran sulfate sodium (DSS)-induced experimental colitis
por: Chao, Liu, et al.
Publicado: (2017) -
Vaccine Development to Treat Alzheimer's Disease Neuropathology in APP/PS1 Transgenic Mice
por: Carrera, Iván, et al.
Publicado: (2012) -
Murine Colitis Modeling using Dextran Sulfate Sodium (DSS)
por: Whittem, Caitlyn G., et al.
Publicado: (2010) -
Cellobiose Prevents the Development of Dextran Sulfate Sodium (DSS)-Induced Experimental Colitis
por: Nishimura, Takashi, et al.
Publicado: (2010)